Bachelot T - Search Results

1

PI3K targeting in breast cancer: the end of the beginning?

Bachelot T, Campone M, Tredan O. Bachelot T, et al. Lancet Oncol. 2016 Jun;17(6):696-697. doi: 10.1016/S1470-2045(16)00148-0. Epub 2016 May 4. Lancet Oncol. 2016. PMID: 27155742 No abstract available.

2

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY; European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Ray-Coquard I, et al. Among authors: bachelot t. Cancer Res. 2009 Jul 1;69(13):5383-91. doi: 10.1158/0008-5472.CAN-08-3845. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549917 Free PMC article.

3

Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study.

Trédan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, Bachelot T, Guastalla JP, Lallemand Y, Faure C, Pérol D, Bachmann P. Trédan O, et al. Among authors: bachelot t. Clin Nutr. 2010 Apr;29(2):187-91. doi: 10.1016/j.clnu.2009.08.003. Epub 2009 Aug 26. Clin Nutr. 2010. PMID: 19713014 Clinical Trial.

4

Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.

Carrabin N, Mithieux F, Meeus P, Trédan O, Guastalla JP, Bachelot T, Labidi SI, Treilleux I, Rivoire M, Ray-Coquard I. Carrabin N, et al. Among authors: bachelot t. Bull Cancer. 2010 Apr;97(4):E23-32. doi: 10.1684/bdc.2010.1063. Bull Cancer. 2010. PMID: 20202920

5

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer.

Belbaraka R, Trédan O, Ray-Coquard I, Chvetzoff G, Bajard A, Pérol D, Ismaili N, Ismaili M, Errihani H, Bachelot T, Rebattu P. Belbaraka R, et al. Among authors: bachelot t. BMC Res Notes. 2010 Jun 10;3:164. doi: 10.1186/1756-0500-3-164. BMC Res Notes. 2010. PMID: 20537187 Free PMC article.

6

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.

Cortes J, Vahdat L, Blum JL, Twelves C, Campone M, Roché H, Bachelot T, Awada A, Paridaens R, Goncalves A, Shuster DE, Wanders J, Fang F, Gurnani R, Richmond E, Cole PE, Ashworth S, Allison MA. Cortes J, et al. Among authors: bachelot t. J Clin Oncol. 2010 Sep 1;28(25):3922-8. doi: 10.1200/JCO.2009.25.8467. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679609 Clinical Trial.

7

Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation.

Campone M, Juin P, André F, Bachelot T. Campone M, et al. Among authors: bachelot t. Crit Rev Oncol Hematol. 2011 Jun;78(3):195-205. doi: 10.1016/j.critrevonc.2010.04.012. Epub 2010 Jun 1. Crit Rev Oncol Hematol. 2011. PMID: 20684884 Review.

8

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.

Galy G, Labidi-Galy SI, Perol D, Bachelot T, Ray-Coquard I, Tredan O, Biron P, Latour JF, Blay JY, Guastalla JP, Favier B. Galy G, et al. Among authors: bachelot t. Breast Cancer Res Treat. 2011 Jul;128(1):187-95. doi: 10.1007/s10549-010-1311-3. Epub 2010 Dec 24. Breast Cancer Res Treat. 2011. PMID: 21184270

9

Validation of prognostic scores for survival in cancer patients beyond first-line therapy.

Trédan O, Ray-Coquard I, Chvetzoff G, Rebattu P, Bajard A, Chabaud S, Pérol D, Saba C, Quiblier F, Blay JY, Bachelot T. Trédan O, et al. Among authors: bachelot t. BMC Cancer. 2011 Mar 15;11:95. doi: 10.1186/1471-2407-11-95. BMC Cancer. 2011. PMID: 21406082 Free PMC article.

10

Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes.

Boyault S, Drouet Y, Navarro C, Bachelot T, Lasset C, Treilleux I, Tabone E, Puisieux A, Wang Q. Boyault S, et al. Among authors: bachelot t. Breast Cancer Res Treat. 2012 Feb;132(1):29-39. doi: 10.1007/s10549-011-1518-y. Epub 2011 Apr 22. Breast Cancer Res Treat. 2012. PMID: 21512767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters